MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

Meeting: 2019 International Congress

Abstract Number: 1724

Keywords: Cognitive dysfunction, Dopamine, Functional magnetic resonance imaging(fMRI)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally.

Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common VNTR alleles: 10-R and 9-R. 10R/10R patients have higher dopamine reuptake and we have previously shown that PD patients with this genotype have higher cortico-striatal activity during Wisconsin-Card-Sorting-Task (WCST), an executive-function task (1).

Method: 73 PD patients (stage 2 or 3 Hoehn & Yahr) were seen at time 1 (T1) and 36 were followed 18 months later (T2). All participants had a blood draw, and their genomic DNA was extracted. The SLC6A3VNTR was amplified by PCR and the product was genotyped by running on a 2% Agarose gel with a ladder. COMTrs4680 genotyping was performed by TaqMan (C2574680950). Participants had a full cognitive assessment and 1-hour MRI session in a 3T GE scanner to obtain structural and fMRI data. Task-based fMRI data of each genetic group (10-R/10-R) vs (9-R/10-R & 9-R/9-R) was analyzed by FSL.

Results: Demographics and SLC6A3genotype for participants are shown in (table1). COMTalleles distribution was not significantly different between the two groups. In longitudinal analysis, 24 (10-R) and 12 (9-R) participants remained. PD patients in 10-R group presented better memory abilities longitudinally, and at T2 when compared to 9-R group (n=36, tL=2.52 p=0.016 and tT2=2.173, p=0.037). Also, 10-R group had significantly better average z-scores of Visuo-Spatial domain and MoCA test compared to 9-R group at T2 (Mann-Whitney(M-W) UVS= 69.5 significance-level= 0.012 and M-W UMoCA= 79.5 significance-level= 0.029).  For longitudinal fMRI analysis, 3 participants from 9-R and 2 participants from 10-R group were removed due to dementia or inability to complete WCST. No region showed activity association in within and between group analysis for planning set-shift (Figure 1 a & b). For execution of set-shift, higher activity was found in right cerebellum of 10-R group compared to 9-R. Higher activity was detected in left superior temporal gyrus of 9-R group compared to 10-R (Figure 1 c & d) (Table 2).

Conclusion: PD patients with 10-R/10-R genotype retain better memory abilities longitudinally and higher MoCA scores than 9-R group. This might be due to faster reuptake of dopamine in 10-R/10-R carriers.  fMRI data is inconsistent at this point and a larger sample size is needed to validate these findings.

Screen Shot 2019-03-01 at 2.25.06 PM

Screen Shot 2019-03-01 at 2.25.33 PM

Screen Shot 2019-03-01 at 2.26.07 PM

References: 1-Habak C, Noreau A, Monchi O, et al. Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson’s disease. (2014).Brain.137(11): 3025–3035.

To cite this abstract in AMA style:

M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi. Specific SLC6A3 variant shows association with better memory in PD patients longitudinally [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/specific-slc6a3-variant-shows-association-with-better-memory-in-pd-patients-longitudinally/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/specific-slc6a3-variant-shows-association-with-better-memory-in-pd-patients-longitudinally/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley